🔓 Unlock the full profile of Simon Read (Mariana Oncology), including verified contact details, financial insights, and professional associations.
See Simon Read Full ProfileBelow are the ✅ Verified Contact Details to help you connect directly:
Email: sim*****@mar******.com
Mobile: 64268*****
Estimated Net Worth 💰 : ₹0 – ₹500+ Cr (approx. $0 – $60M)
Key Insights You Should Know About This Individual
- Simon Read is the Founder and CEO of Mariana Oncology, a role commenced in January 2021, focusing on innovative cancer treatment solutions.
- Mariana Oncology has shown strong growth, with a reported 65.79% headcount growth over the past six months and 55.77% growth over the past two years.
- Simon serves on the Scientific Advisory Board of Q32 Bio Inc., contributing expertise in the field of biopharmaceuticals.
- As an advisor at Atlas Venture since June 2020, Simon plays a role in guiding investments in early-stage biotechnology companies.
- Simon co-founded TRIANA Biomedicines and served as a Board Member until February 2024, focusing on innovative biomedicine solutions.
- Previously, Simon held the position of Chief Scientific Officer at Ra Pharmaceuticals from April 2016 until April 2020, leading research initiatives in therapeutic development.
- At Grünenthal, Simon worked as Vice President and Head of Innovative Medicines from December 2011 to March 2016, overseeing drug development projects.
- Experience includes a significant role at Roche Pharmaceuticals leading Biomarker and Experimental Medicine from September 2008 to December 2011.
- While at AstraZeneca, Simon held the position of Associate Director in Disease and Translational Science from January 2004 to January 2008, contributing to drug discovery programs.